MX9102702A - ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES. - Google Patents

ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.

Info

Publication number
MX9102702A
MX9102702A MX9102702A MX9102702A MX9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A
Authority
MX
Mexico
Prior art keywords
interfered
proliferative
lung diseases
oral inhalation
treat asthma
Prior art date
Application number
MX9102702A
Other languages
Spanish (es)
Inventor
Robert J Spiegel
Francis M Cuss
Keith B Nolop
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9102702A publication Critical patent/MX9102702A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9102702A 1990-12-21 1991-12-19 ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES. MX9102702A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63156590A 1990-12-21 1990-12-21
US63155290A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
MX9102702A true MX9102702A (en) 1992-06-01

Family

ID=27091422

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102702A MX9102702A (en) 1990-12-21 1991-12-19 ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.

Country Status (6)

Country Link
AU (1) AU9132091A (en)
IE (1) IE914444A1 (en)
IL (1) IL100415A0 (en)
MX (1) MX9102702A (en)
PT (1) PT99837A (en)
WO (1) WO1992011025A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001502666A (en) 1996-09-12 2001-02-27 ジェネメディシン，インコーポレイテッド Compositions and methods for pulmonary gene delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ZA873743B (en) * 1986-05-27 1987-11-25 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE83381T1 (en) * 1986-10-22 1993-01-15 Schering Corp USE OF RECOMBINATED HUMAN ALPHA INTERFERON IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF THE AIDS VIRUS.
WO1988009673A1 (en) * 1987-06-02 1988-12-15 Schering Corporation Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
WO1990000406A1 (en) * 1988-07-05 1990-01-25 Schering Corporation Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
ATE92333T1 (en) * 1988-12-01 1993-08-15 Schering Corp MEDICATIONS FOR THE INTRALESION TREATMENT OF SCALP-LIKE CELL CARCINOMA WITH RECOMBINANT HUMAN ALPHA INTERFERON.

Also Published As

Publication number Publication date
WO1992011025A2 (en) 1992-07-09
AU9132091A (en) 1992-07-22
WO1992011025A3 (en) 1992-09-17
PT99837A (en) 1992-12-31
IE914444A1 (en) 1992-07-01
IL100415A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
FI891690L (en) FOERBAETTRAD INHALATION FOOTWEAR FOER BARNPATIENTER MED ASTHMA.
TR199501635A1 (en) Therapeutic preparations taken by inhalation.
FI875358A7 (en) Inhaler
FI925673A7 (en) Use of 5,10,15,20-tetrakis(r-carboxyphenyl)porphine for the diagnosis and treatment of lung cancer
DE59000161D1 (en) RESPIRATORY MASK.
DE3888838D1 (en) RESPIRATORY MASK.
DE69528237D1 (en) INHALER
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
FI915543A7 (en) POWDER INHALER.
EP0050654A4 (en) Inhalation spirometric device for administering pulmonary medication.
DE3369682D1 (en) 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments
NO893062D0 (en) USE OF ISOKINOLIC COMPOUNDS, SPECIFICALLY INHALATION PREPARATIONS.
ATE271852T1 (en) IMPROVED INHALATION PREPARATIONS
FI823740A7 (en) Disposable respirator half mask.
IL65184A (en) Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
ZA816417B (en) Pharmaceutical composition,especially for treating infectious diseases of the respiratory tract
DE59203456D1 (en) Liposomes containing volatile inhalation anesthetics, their preparation and use.
DE3865818D1 (en) MEDICINAL PREPARATION FOR INHALATION APPLICATIONS.
FI821288A7 (en) Phenethanolamine derivatives, their preparation and their therapeutic use.
IL100332A0 (en) Oral administration of alpha interferon to treat lung malignancies
FI963753A7 (en) New drug to treat respiratory viral disease
IL100415A0 (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
ITFI920029U1 (en) INHALER TO ADD AIR TO INSPIRE, FOR USE IN THE PRESENCE OF HARMFUL ATMOSPHERES.